Bowel ProblemsInflammatory Bowel Disease Bowel ProblemsDermatologyFamily PracticeGastroenterologyInternal MedicinePathologyConditionsSkin DisordersDigestive SystemInflammatory Bowel DiseaseGeneral HealthInflammation
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, Feb. 28, 2020 (HealthDay News) -- There appears to be a link between hidradenitis suppurativa (HS) and inflammatory bowel disease (IBD), according to a review published in the February issue of the International Journal of Dermatology.
Kevin Phan, M.D., from the University of New South Wales in Sydney, and colleagues conducted a systematic literature review to identify studies evaluating the association between HS and IBD.
Based on six included studies, the researchers observed a significant association between HS and IBD. When data were pooled in a meta-analysis, the adjusted effect sizes showed an odds ratio of 2.12. There was a significant association between HS and both Crohn disease (odds ratio, 2.25) and ulcerative colitis (odds ratio, 1.56).
"Our results highlight that all patients with HS should be clinically screened for symptoms of IBD and symptomatic patients referred for further investigations," the authors write. "It should also be noted that cutaneous Crohn's disease and inguinal/perineal HS have a clinical overlap, and this needs to be considered in any patient with severe perineal HS."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 26, 2022
Read this Next
Other Trending Articles